文献速递甲状腺与颈部外科围术期管理与 ERAS

原发性甲状旁腺功能亢进症患者的性别差异

Sex differences in patients with primary hyperparathyroidism.
PubMed 文献 · Surgery · 2023-11-18

本研究基于2016年1月至2019年12月前瞻性数据库,纳入初次甲状旁腺切除术后6个月治愈的原发性甲状旁腺功能亢进症患者701例,术前及术后采用Pasieka甲状旁腺切除评估评分(0-1,300)评估症状。女性术前评分中位数高于男性(155 vs 80.5,P < .001),术后6个月女性评分下降48%(155 vs 80,P < .001),男性下降幅度较小(80.5 vs 57.5,P = .048)。

要点

  • 女性术前Pasieka评分中位数155高于男性80.5(P < .001)。
  • 术后6个月女性评分下降48%(155 vs 80,P < .001)。
  • 男性术后6个月评分下降幅度较小(80.5 vs 57.5,P = .048)。

核心结论

  • 采用Pasieka甲状旁腺切除评估评分评估时,女性在治愈性甲状旁腺切除术后症状改善明显。
  • 男性症状是否改善较不明显,可能归因于结局工具在开发和验证中的差异。

研究设计与样本

  • 对2016年1月至2019年12月前瞻性维护的原发性甲状旁腺功能亢进症患者数据库进行回顾,纳入初次甲状旁腺切除术后6个月治愈者。
  • 所有患者在术前和术后访视时完成症状评估,包括13项Pasieka甲状旁腺切除评估评分参数(视觉模拟量表,总分0-1,300)及总体生活质量和健康状态。

主要发现

  • 研究队列以女性为主(77%,541/701)。
  • 女性术前Pasieka评分中位数高于男性(155,0-1,190 vs 80.5,0-855,P < .001)。
  • 无症状原发性甲状旁腺功能亢进症(Pasieka评分=0)比例女性12.5% vs 男性7%(P = .042)。
  • 女性术后初次访视Pasieka评分下降35%(中位数155 vs 100,P < .001),6个月时下降48%(155 vs 80,P < .001)。
  • 男性术后初次访视Pasieka评分变化较小(80.5 vs 70,P = .036),6个月时(80.5 vs 57.5,P = .048)。

关键数值与推荐

  • Pasieka甲状旁腺切除评估评分总分范围0-1,300。
  • 无症状定义为Pasieka甲状旁腺切除评估评分=0。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differences in presenting symptoms of primary hyperparathyroidism and outcomes of parathyroidectomy between sexes have been described, but whether these can be assessed by perioperative use of a validated tool, such as the Pasieka Parathyroidectomy Assessment Score, is unknown. METHOD: All patients with primary hyperparathyroidism were asked to complete symptom assessment at the preoperative and postoperative visits. The assessment included a query for 13 Pasieka Parathyroidectomy Assessment Score parameters evaluated using a visual analog scale as described by Pasieka (summative score 0-1,300), and general quality of life and wellness. A review of a prospectively maintained database of primary hyperparathyroidism patients (January 2016-December 2019) was performed, and those who had a 6-month cure after initial parathyroidectomy were included. RESULTS: The study cohort was mostly women (77%, 541/701). The median preoperative Pasieka Parathyroidectomy Assessment Score was higher in women (155, 0-1,190) than in men (80.5, 0-855, P < .001), although there were similar rates of asymptomatic primary hyperparathyroidism (Pasieka Parathyroidectomy Assessment Score = 0, 12.5% vs 7%, P = .042). After curative parathyroidectomy, women reported a substantial reduction in symptomatology, with Pasieka Parathyroidectomy Assessment Score declining by 35% at initial postoperative visit (median, 155 vs 100, P < .001), further decreasing to 48% by 6 months (155 vs 80, P < .001). The Pasieka Parathyroidectomy Assessment Score in men did change but to a much smaller degree at both the initial postoperative visit (80.5 vs 70; P = .036) and at 6 months (80.5 vs 57.5; P = .048). CONCLUSION: When assessed with the Pasieka Parathyroidectomy Assessment Score, improvement in symptoms was clearly demonstrated for women after curative parathyroidectomy. Whether symptom improvement also occurs in men is less apparent but may be due to disparities in the development and validation of outcomes tools in general.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Baugh KA, Liu JB, Yip L, et al. Sex differences in patients with primary hyperparathyroidism. Surgery. 2023. PMID: 37980200. doi:10.1016/j.surg.2023.07.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。